A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer
Latest Information Update: 19 Jun 2024
At a glance
- Drugs Ascorbic acid (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 May 2024 Status changed from active, no longer recruiting to completed.
- 17 Aug 2022 Planned End Date changed from 1 Dec 2027 to 1 Dec 2024.
- 15 Nov 2021 Status changed from recruiting to active, no longer recruiting.